SETTLEMENT AGREEMENTSettlement Agreement • October 8th, 2019 • Amag Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 8th, 2019 Company Industry JurisdictionThis SETTLEMENT AGREEMENT (this “Agreement”) is made and entered into as of October 8, 2019, by and among AMAG Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on the one hand, and Caligan Partners LP, a Delaware limited partnership, Caligan Partners CV II LP, a Cayman Islands exempted limited partnership, David E. Johnson, an individual, and Paul Fonteyne, an individual (the foregoing, collectively with each of their respective Affiliates, the “Investor Group”), on the other hand. The Company and the Investor Group are each herein referred to as a “party” and collectively, the “parties.”